Ganga Pharmaceuticals Reports H1 FY27 Results with Profit Decline
Ganga Pharmaceuticals Ltd · Outcome · 02 Nov 2026, 10:10 pm
Ganga Pharmaceuticals Reports H1 FY27 Results with Profit Decline Ganga Pharmaceuticals posted revenue from operations of ₹141.63 lakh for the half-year ended 30th Sep'26, rising 3.6% YoY from ₹136.65 lakh in the corresponding period ended 30th Sep'25. Total income reached ₹155.27 lakh versus ₹146.91 lakh YoY. However, net profit dropped 66.2% YoY to ₹1.86 lakh compared to ₹5.50 lakh, pressured by higher raw material costs of ₹80.42 lakh and employee expenses of ₹32.72 lakh. Half-year basic and diluted EPS declined to ₹0.03 from ₹0.04 YoY.
Original exchange filing (PDF)
More announcements from Ganga Pharmaceuticals Ltd
- Un-audited Financial Results of the Company for the half year ended September 30, 2026 · 02 Nov 2026
- Ganga Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve inter-alia, the Un-audited .... · 02 Nov 2026
- Re-appointment of Managing Director · 27 Sept 2026
- Voting Results of 37th Annual General Meeting along with the Scrutinizer Report · 27 Sept 2026
- Proceeding of the AGM held on Saturday, September 26, 2026 · 27 Sept 2026
- The Company has sent Letter to the Shareholder for aGM whose Email Id is not resgistered with the RTA · 02 Sept 2026
- Please find enclosed herewith the Notice of the AGM for F.Y. 2025-26 · 02 Sept 2026
- Please find enclosed herewith the Annual Report for F.Y. 2025-26 · 02 Sept 2026
